Overview
FULC market data
Price History
FULC price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for FULC. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
8-K filing — Fulcrum Therapeutics, Inc. (FULC)SEC EDGAR · Jun 11, 2026, 8:30 PM
UPDATED: Fulcrum Therapeutics Launches Restructuring Plan Following Discontinuation Of Pociredir For Sickle Cell Disease, Cutting Workforce By 85% From 57 To 9 Employees And Recording ~$4.2M In Restructuring ChargesBenzinga · Jun 4, 2026, 8:20 PM
What's Going On With Fulcrum Therapeutics Stock On Thursday?Benzinga · Jun 4, 2026, 2:25 PM
JP Morgan Downgrades Fulcrum Therapeutics to UnderweightBenzinga · Jun 3, 2026, 3:35 PM
Stifel Downgrades Fulcrum Therapeutics to Hold, Lowers Price Target to $3Benzinga · Jun 2, 2026, 5:57 PM
Piper Sandler Downgrades Fulcrum Therapeutics to Underweight, Lowers Price Target to $3Benzinga · Jun 2, 2026, 5:23 PM
Truist Securities Downgrades Fulcrum Therapeutics to Hold, Lowers Price Target to $4Benzinga · Jun 2, 2026, 4:15 PM
Leerink Partners Downgrades Fulcrum Therapeutics to Market Perform, Lowers Price Target to $4Benzinga · Jun 2, 2026, 1:23 PM
CrowdStrike To Gain 7%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jun 2, 2026, 1:15 PM
This Goldman Sachs Analyst Turns Bearish; Here Are Top 4 Downgrades For TuesdayBenzinga · Jun 2, 2026, 12:59 PM